Completed OBSERVATIONAL NCT01076374

MEDTRONIC ADAPTA, VERSA AND SENSIA nEw3 POST APPROVAL STUDY

Medtronic Adapta/Versa/Sensia Long Term Reliability Study

Sponsor: Medtronic

Updated 8 times since 2017 Last updated: Apr 24, 2018 Started: Jul 31, 2008 Primary completion: Oct 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Arrhythmia and Bradycardia, this trial is completed. The trial is conducted by Medtronic and has accumulated 8 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

May 2018 — Jun 2018 [monthly]

Completed

Status: Unknown Status → Completed
Apr 2018 — May 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic

Data source: Medtronic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Albany, United States , Albuquerque, United States , Alexandria, United States , Anchorage, United States , Atlanta, United States , Austin, United States , Bakersfield, United States , Baton Rouge, United States , Belgrade, Serbia and 115 more locations